Ziprasidone in Early Onset Schizophrenia Spectrum Disorders

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Schizophrenia
Interventions
DRUG

Ziprasidone

20mg pills, dosing will be flexible, ranging from 10 to 160 mg divided BID or TID for the duration of the 52 week trial. In very rare cases, if the subject has shown some benefit and no side effects at a dose of 160mg and the treating clinician feels a further dose increase is necessary, the case would need to be presented to all of the other Principal Investigators for special consideration of further dose increases in 20 mg increments to an absolute maximal dose of 220mg.

Trial Locations (4)

27599

University of North Carolina, Chapel Hill, Chapel Hill

44106

Case Western Reserve University, Cleveland

98125

University of Washington, Seattle

02155

Harvard University, Medford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of North Carolina, Chapel Hill

OTHER